Structures by: Burgos I.
Total: 6
<i>N</i>,2,6,11-Tetramethyl-<i>N</i>-phenyl-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepin-4-amine
C22H24N4
Acta Crystallographica Section C (2018) 74, 3
a=11.2020(19)Å b=16.609(3)Å c=19.850(6)Å
α=90° β=90° γ=90°
4-(1<i>H</i>-Benzo[<i>d</i>]imidazol-1-yl)-6,11-dimethyl-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepine 0.374-hydrate
C21H19N5,0.374(H2O)
Acta Crystallographica Section C (2018) 74, 3
a=11.1086(5)Å b=8.7806(3)Å c=17.7753(9)Å
α=90° β=103.651(2)° γ=90°
5-Allyl-6-(1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)-<i>N</i>-methyl-<i>N</i>-(4-methylphenyl)pyrimidin-4-amine
C22H21N5
Acta Crystallographica Section C (2018) 74, 3
a=9.425(2)Å b=11.184(3)Å c=17.321(6)Å
α=90° β=101.091(11)° γ=90°
6,7,9,11-Tetramethyl-4-(5-methyl-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]pyrimido[5,4-<i>f</i>]azepine
C24H25N5
Acta Crystallographica Section C (2018) 74, 3
a=9.7866(13)Å b=10.2122(15)Å c=10.9551(14)Å
α=97.816(9)° β=112.433(8)° γ=94.149(8)°
(RS)-8-chloro-6-methyl-1,2,6,7-tetrahydropyrimido[5',4':6,7]azepino[3,2,1-hi]indole
C15H14ClN3
Acta Crystallographica Section C (2016) 72, 1 52-56
a=6.6250(3)Å b=22.4796(13)Å c=8.6355(4)Å
α=90° β=100.610(3)° γ=90°
(RS)-9-chloro-7-methyl-2,3,7,8-tetrahydro-1H-pyrimido[5',4':6,7]azepino[3,2,1-ij]-quinoline
C16H16ClN3
Acta Crystallographica Section C (2016) 72, 1 52-56
a=8.1840(10)Å b=9.5399(12)Å c=10.2185(19)Å
α=104.471(7)° β=101.049(6)° γ=111.324(5)°